환자 혈액 관리 시장 규모, 점유율 및 성장 분석 : 제품 유형별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Patient Blood Management Market size was valued at USD 14.66 Billion in 2024 and is poised to grow from USD 15.58 Billion in 2025 to USD 25.41 Billion by 2033, growing at a CAGR of 6.3% during the forecast period (2026-2033).

The global patient blood management (PBM) market is witnessing robust growth, fueled by the rising incidence of chronic diseases, increased surgical procedures, and heightened awareness of the advantages of PBM strategies. By optimizing patient care for those potentially requiring blood transfusions, PBM aims to enhance outcomes while minimizing the use of transfusions. Chronic ailments, including cardiovascular disorders and cancer, often necessitate surgical interventions, which can involve transfusions. However, healthcare providers are progressively implementing PBM techniques to mitigate transfusion-related risks, thus driving demand for such solutions. The focus on improving surgical results, reducing complications, and decreasing hospital stays further promotes the adoption of PBM protocols, emphasizing alternatives to transfusions and methods to bolster patient resilience against anemia.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Patient Blood Management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Patient Blood Management Market Segments Analysis

Global Patient Blood Management Market is segmented by Product Type, Application, End User and region. Based on Product Type, the market is segmented into Blood Management Devices, Blood Components, Pharmaceuticals and Others. Based on Application, the market is segmented into Surgery, Trauma Care, Oncology, Obstetrics and Others. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Patient Blood Management Market

The Global Patient Blood Management market is propelled by significant advancements in transfusion medicine, characterized by the introduction of innovative techniques and technologies that enhance blood management. These developments have substantially increased the safety and efficacy of blood transfusions, which in turn fosters greater acceptance and implementation of patient blood management practices. As healthcare providers recognize the benefits of these advancements, there is a growing emphasis on optimizing blood use and minimizing waste, further driving the demand for comprehensive blood management solutions across various healthcare settings. This ongoing evolution underscores the importance of adopting best practices to ensure high-quality patient care.

Restraints in the Global Patient Blood Management Market

The adoption of patient blood management practices frequently requires shifting away from traditional transfusion methods and established medical protocols. This transition can be hindered by resistance to change, as many healthcare professionals may prefer familiar practices. Additionally, accommodating the preferences of physicians while ensuring they receive sufficient training and education on new approaches can pose significant challenges. These factors collectively inhibit the broader acceptance and successful implementation of patient blood management strategies in clinical settings, creating a barrier that must be addressed for effective change to occur within the healthcare system.

Market Trends of the Global Patient Blood Management Market

A prominent trend shaping the global patient blood management market is the shift towards personalized and evidence-based transfusion practices that prioritize patient-specific needs. This approach aims to optimize blood use and minimize risks associated with unnecessary transfusions, including transfusion reactions and potential infections. As healthcare systems strive for improved outcomes and cost-effectiveness, there is a growing emphasis on integrating advanced technologies and data analytics to inform clinical decision-making. This transition not only enhances patient safety but also aligns with broader healthcare initiatives focused on value-based care, thereby promoting a more efficient and responsible utilization of blood resources in clinical settings.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Analysis
• Patent Analysis

Global Patient Blood Management Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Blood Management Devices
• Blood Components
• Pharmaceuticals
• Others

Global Patient Blood Management Market Size by Application & CAGR (2026-2033)

• Market Overview
• Surgery
• Trauma Care
• Oncology
• Obstetrics
• Others

Global Patient Blood Management Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

Global Patient Blood Management Market Size & CAGR (2026-2033)

• North America (Product Type, Application, End User)
  • US
  • Canada
• Europe (Product Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• F. Hoffmann-La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols, S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haemonetics Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Werfen, S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics Holdings plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius SE & Co. KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macopharma SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sarstedt AG & Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations